Sodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome Prevention

NCT04778787 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
370
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

I.M. Sechenov First Moscow State Medical University